rss
Br J Sports Med 2008;42:581-584 doi:10.1136/bjsm.2007.037945
  • Original article

Fast and slow myosins as markers of muscle injury

This article has been Unlocked
  1. M Guerrero1,
  2. M Guiu-Comadevall1,
  3. J A Cadefau1,
  4. J Parra1,
  5. R Balius2,
  6. A Estruch2,
  7. G Rodas3,
  8. J L Bedini4,
  9. R Cussó1
  1. 1
    University of Barcelona, Barcelona, Spain
  2. 2
    Centre d’Estudis d’Alt Rendiment Esportiu (CEARE), Barcelona, Spain
  3. 3
    FC Barcelona (FCB), Barcelona, Spain
  4. 4
    Hospital Clínic i Provincial de Barcelona, Barcelona, Spain
  1. Professor R Cussó, Ciencias Fisiologicas I, Barcelona University, c/Casanova 143, 08036 Barcelona, Spain; mcusso{at}ub.edu
  • Accepted 9 August 2007
  • Published Online First 10 December 2007

Abstract

Objective: The diagnosis of muscular lesions suffered by athletes is usually made by clinical criteria combined with imaging of the lesion (ultrasonography and/or magnetic resonance) and blood tests to detect the presence of non-specific muscle markers. This study was undertaken to evaluate injury to fast and slow-twitch fibres using specific muscle markers for these fibres.

Methods: Blood samples were obtained from 51 non-sports people and 38 sportsmen with skeletal muscle injury. Western blood analysis was performed to determine fast and slow myosin and creatine kinase (CK) levels. Skeletal muscle damage was diagnosed by physical examination, ultrasonography and magnetic resonance and biochemical markers.

Results: The imaging tests were found to be excellent for detecting and confirming grade II and III lesions. However, grade I lesions were often unconfirmed by these techniques. Grade I lesions have higher levels of fast myosin than slow myosin with a very small increase in CK levels. Grade II and III lesions have high values of both fast and slow myosin.

Conclusions: The evaluation of fast and slow myosin in the blood 48 h after the lesion occurs is a useful aid for the detection of type I lesions in particular, since fast myosin is an exclusive skeletal muscle marker. The correct diagnosis of grade I lesions can prevent progression of the injury in athletes undergoing continual training sessions and competitions, thus aiding sports physicians in their decision making.

Footnotes

  • Funding: This study was financed mainly by two grants from the Consell Català de l’Esport (Catalan Sports Council of the Generalitat of Catalunya) and a small collaboration from the Consejo Superior de Deportes (Higher Council for Sports of the MEC) and from the FISS of the Instituto Carlos III (Red de Centros RCMN-C03708).

  • Competing interests: None.

  • Ethics approval: This study was approved by the ethics committee of the University of Barcelona and the ethics committee of the Hospital Clinic i Provincial of Barcelona.

This article has been Unlocked

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.